Safety and Immunological Responses to Human Mesenchymal Stem Cell Therapy in Difficult-To-Treat HIV-1-infected Patients

AIDS - United States
doi 10.1097/qad.0b013e32835fab77
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Relaxin-Based Stem Cell Gene Therapy to Treat Breast Cancer

Science-Business eXchange
2009English

Immunologic Activity and Safety of Autologous HIV RNA-electroporated Dendritic Cells in HIV-1 Infected Patients Receiving Antiretroviral Therapy

Clinical Immunology
AllergyImmunology
2010English

Bone Marrow Mesenchymal Stromal Cells to Treat Complications Following Allogeneic Stem Cell Transplantation

Tissue Engineering - Part B: Reviews
BiochemistryBioengineeringBiomaterialsBiomedical Engineering
2014English

Response of HIV-associated Proteinuria to Antiretroviral Therapy in HIV-1-infected Children

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2006English

Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2016English

Tissue Constructs With Human Adipose-Derived Mesenchymal Stem Cells to Treat Bone Defects in Rats

Materials
Materials ScienceCondensed Matter Physics
2019English

Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans

PLoS ONE
Multidisciplinary
2011English

Prenatal Transplantation of Mesenchymal Stem Cells to Treat Osteogenesis Imperfecta

Frontiers in Pharmacology
Pharmacology
2014English

Speech Therapy — A Non-Pharmacological Method to Manage Difficult-To-Treat Chronic Cough

Advances in Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy